Svjetlana Lovric1, Humphrey Fang1, Virginia Vega-Warner2, Carolin E Sadowski1, Heon Yung Gee1, Jan Halbritter1, Shazia Ashraf1, Pawaree Saisawat2, Neveen A Soliman3, Jameela A Kari4, Edgar A Otto2, Friedhelm Hildebrandt5. 1. Division of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; 2. Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan; 3. Department of Pediatrics, Center of Pediatric Nephrology & Transplantation, Kasr Al Ainy School of Medicine, Cairo University and Egyptian Group of Orphan Diseases, Cairo, Egypt; 4. Department of Pediatrics, King Abdulaziz University Hospital, Jeddah, Saudi Arabia; and. 5. Division of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Howard Hughes Medical Institute, Chevy Chase, Maryland friedhelm.hildebrandt@childrens.harvard.edu.
Abstract
BACKGROUND AND OBJECTIVES: In steroid-resistant nephrotic syndrome (SRNS), >21 single-gene causes are known. However, mutation analysis of all known SRNS genes is time and cost intensive. This report describes a new high-throughput method of mutation analysis using a PCR-based microfluidic technology that allows rapid simultaneous mutation analysis of 21 single-gene causes of SRNS in a large number of individuals. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study screened individuals with SRNS; samples were submitted for mutation analysis from international sources between 1996 and 2012. For proof of principle, a pilot cohort of 48 individuals who harbored known mutations in known SRNS genes was evaluated. After improvements to the method, 48 individuals with an unknown cause of SRNS were then examined in a subsequent diagnostic study. The analysis included 16 recessive SRNS genes and 5 dominant SRNS genes. A 10-fold primer multiplexing was applied, allowing PCR-based amplification of 474 amplicons in 21 genes for 48 DNA samples simultaneously. Forty-eight individuals were indexed in a barcode PCR, and high-throughput sequencing was performed. All disease-causing variants were confirmed via Sanger sequencing. RESULTS: The pilot study identified the genetic cause of disease in 42 of 48 (87.5%) of the affected individuals. The diagnostic study detected the genetic cause of disease in 16 of 48 (33%) of the affected individuals with a previously unknown cause of SRNS. Seven novel disease-causing mutations in PLCE1 (n=5), NPHS1 (n=1), and LAMB2 (n=1) were identified in <3 weeks. Use of this method could reduce costs to 1/29th of the cost of Sanger sequencing. CONCLUSION: This highly parallel approach allows rapid (<3 weeks) mutation analysis of 21 genes known to cause SRNS at a greatly reduced cost (1/29th) compared with traditional mutation analysis techniques. It detects mutations in about 33% of childhood-onset SRNS cases.
BACKGROUND AND OBJECTIVES: In steroid-resistant nephrotic syndrome (SRNS), >21 single-gene causes are known. However, mutation analysis of all known SRNS genes is time and cost intensive. This report describes a new high-throughput method of mutation analysis using a PCR-based microfluidic technology that allows rapid simultaneous mutation analysis of 21 single-gene causes of SRNS in a large number of individuals. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study screened individuals with SRNS; samples were submitted for mutation analysis from international sources between 1996 and 2012. For proof of principle, a pilot cohort of 48 individuals who harbored known mutations in known SRNS genes was evaluated. After improvements to the method, 48 individuals with an unknown cause of SRNS were then examined in a subsequent diagnostic study. The analysis included 16 recessive SRNS genes and 5 dominant SRNS genes. A 10-fold primer multiplexing was applied, allowing PCR-based amplification of 474 amplicons in 21 genes for 48 DNA samples simultaneously. Forty-eight individuals were indexed in a barcode PCR, and high-throughput sequencing was performed. All disease-causing variants were confirmed via Sanger sequencing. RESULTS: The pilot study identified the genetic cause of disease in 42 of 48 (87.5%) of the affected individuals. The diagnostic study detected the genetic cause of disease in 16 of 48 (33%) of the affected individuals with a previously unknown cause of SRNS. Seven novel disease-causing mutations in PLCE1 (n=5), NPHS1 (n=1), and LAMB2 (n=1) were identified in <3 weeks. Use of this method could reduce costs to 1/29th of the cost of Sanger sequencing. CONCLUSION: This highly parallel approach allows rapid (<3 weeks) mutation analysis of 21 genes known to cause SRNS at a greatly reduced cost (1/29th) compared with traditional mutation analysis techniques. It detects mutations in about 33% of childhood-onset SRNS cases.
Authors: Bugsu Ovunc; Edgar A Otto; Virginia Vega-Warner; Pawaree Saisawat; Shazia Ashraf; Gokul Ramaswami; Hanan M Fathy; Dominik Schoeb; Gil Chernin; Robert H Lyons; Engin Yilmaz; Friedhelm Hildebrandt Journal: J Am Soc Nephrol Date: 2011-09-08 Impact factor: 10.121
Authors: Simone Sanna-Cherchi; Katelyn E Burgess; Shannon N Nees; Gianluca Caridi; Patricia L Weng; Monica Dagnino; Monica Bodria; Alba Carrea; Maddalena A Allegretta; Hyunjae R Kim; Brittany J Perry; Maddalena Gigante; Lorraine N Clark; Sergey Kisselev; Daniele Cusi; Loreto Gesualdo; Landino Allegri; Francesco Scolari; Vivette D'Agati; Lawrence S Shapiro; Carmine Pecoraro; Teresa Palomero; Gian M Ghiggeri; Ali G Gharavi Journal: Kidney Int Date: 2011-06-22 Impact factor: 10.612
Authors: Cristina Has; Giuseppina Spartà; Dimitra Kiritsi; Lisa Weibel; Alexander Moeller; Virginia Vega-Warner; Aoife Waters; Yinghong He; Yair Anikster; Philipp Esser; Beate K Straub; Ingrid Hausser; Detlef Bockenhauer; Benjamin Dekel; Friedhelm Hildebrandt; Leena Bruckner-Tuderman; Guido F Laube Journal: N Engl J Med Date: 2012-04-19 Impact factor: 91.245
Authors: Jan Halbritter; Katrina Diaz; Moumita Chaki; Jonathan D Porath; Brendan Tarrier; Clementine Fu; Jamie L Innis; Susan J Allen; Robert H Lyons; Constantinos J Stefanidis; Heymut Omran; Neveen A Soliman; Edgar A Otto Journal: J Med Genet Date: 2012-12 Impact factor: 6.318
Authors: Fatih Ozaltin; Binghua Li; Alysha Rauhauser; Sung-Wan An; Oguz Soylemezoglu; Ipek Isik Gonul; Ekim Z Taskiran; Tulin Ibsirlioglu; Emine Korkmaz; Yelda Bilginer; Ali Duzova; Seza Ozen; Rezan Topaloglu; Nesrin Besbas; Shazia Ashraf; Yong Du; Chaoying Liang; Phylip Chen; Dongmei Lu; Komal Vadnagara; Susan Arbuckle; Deborah Lewis; Benjamin Wakeland; Richard J Quigg; Richard F Ransom; Edward K Wakeland; Matthew K Topham; Nicolas G Bazan; Chandra Mohan; Friedhelm Hildebrandt; Aysin Bakkaloglu; Chou-Long Huang; Massimo Attanasio Journal: J Am Soc Nephrol Date: 2012-12-28 Impact factor: 14.978
Authors: Cynthia C Nast; Kevin V Lemley; Jeffrey B Hodgin; Serena Bagnasco; Carmen Avila-Casado; Stephen M Hewitt; Laura Barisoni Journal: Semin Nephrol Date: 2015-05 Impact factor: 5.299
Authors: Martin Kann; Sandrine Ettou; Youngsook L Jung; Maximilian O Lenz; Mary E Taglienti; Peter J Park; Bernhard Schermer; Thomas Benzing; Jordan A Kreidberg Journal: J Am Soc Nephrol Date: 2015-01-30 Impact factor: 10.121
Authors: Sneh Lata; Maddalena Marasa; Yifu Li; David A Fasel; Emily Groopman; Vaidehi Jobanputra; Hila Rasouly; Adele Mitrotti; Rik Westland; Miguel Verbitsky; Jordan Nestor; Lindsey M Slater; Vivette D'Agati; Marcin Zaniew; Anna Materna-Kiryluk; Francesca Lugani; Gianluca Caridi; Luca Rampoldi; Aditya Mattoo; Chad A Newton; Maya K Rao; Jai Radhakrishnan; Wooin Ahn; Pietro A Canetta; Andrew S Bomback; Gerald B Appel; Corinne Antignac; Glen S Markowitz; Christine K Garcia; Krzysztof Kiryluk; Simone Sanna-Cherchi; Ali G Gharavi Journal: Ann Intern Med Date: 2017-12-05 Impact factor: 25.391
Authors: Matthew G Sampson; Catherine C Robertson; Sebastian Martini; Laura H Mariani; Kevin V Lemley; Christopher E Gillies; Edgar A Otto; Jeffrey B Kopp; Anne Randolph; Virginia Vega-Warner; Felix Eichinger; Viji Nair; Debbie S Gipson; Daniel C Cattran; Duncan B Johnstone; John F O'Toole; Serena M Bagnasco; Peter X Song; Laura Barisoni; Jonathan P Troost; Matthias Kretzler; John R Sedor Journal: J Am Soc Nephrol Date: 2015-07-06 Impact factor: 10.121